Crossmark

Comparative in vitro analysis of sulbactam-durlobactam against extensively drug resistant (XDR) and non-XDR carbapenem-resistant Acinetobacter baumannii (CRAB) clinical isolates collected from a tertiary care facility in North India

Crossref DOI link: https://doi.org/10.1007/s10096-025-05335-x

Published Online: 2025-10-30

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nityadarshini, Neha

Biswas, Jaya

Gautam, Hitender

Bordoloi, Tamanna

Batra, Priyam

Mohapatra, Sarita

Sood, Seema

Dhawan, Benu

Das, Bimal Kumar
License Information

Text and Data Mining valid from 2025-10-30

Version of Record valid from 2025-10-30
More Information

Article History

Received: 25 June 2025

Accepted: 22 October 2025

First Online: 30 October 2025

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Ethics Committee (AIIMSA2632/06.12.2024).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below